We are excited to announce that the MIND program has been awarded a grant by the Etheridge Foundation! The primary goal of the funded project is to clarify the impact of a novel high-cannabidiol (CBD) product on pain, related symptomatology, and conventional medication use – particularly opioids.
Read more here.
Comments